Plasma levels of neurogenic inflammation related neuropeptides in pediatric patients with community-acquired pneumonia and their potential diagnostic value in distinguishing viral and bacterial pneumonia

被引:1
|
作者
Bekdas, Mervan [1 ]
Saygi, Bilgi [1 ]
Kilinc, Yasemin Baranoglu [2 ]
Kilinc, Erkan [3 ]
机构
[1] Bolu Abant Izzet Baysal Univ, Fac Med, Dept Pediat, Bolu, Turkiye
[2] Bolu Izzet Baysal State Hosp, Dept Pediat, Bolu, Turkiye
[3] Abant Izzet Baysal Univ, Fac Med, Dept Physiol, Bolu, Turkiye
关键词
Community-acquired pneumonia; Children; Neurogenic inflammation; Neuropeptides; PEPTIDE; PROCALCITONIN; BIOMARKER; NEURONS;
D O I
10.1007/s00431-023-05417-y
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Neurogenic inflammation is involved in the development and progression of respiratory inflammatory diseases. However, its role in community-acquired pneumonia (CAP) remains unclear. We therefore aimed to investigate plasma levels of neurogenic inflammation-related neuropeptides, calcitonin gene-related peptide (CGRP), substance P (SP), vasoactive intestinal peptide (VIP) and neuropeptide Y (NPY), and procalcitonin (PCT) in pediatric patients with CAP and to assess their diagnostic value in viral and bacterial/mixed pneumonia. A total of 124 pediatric patients with CAP (1 month-18 years old) and 56 healthy children of similar ages were prospectively enrolled. The patients were classified as viral (n = 99) and bacterial/mixed (n = 25) pneumonia. Plasma levels of the peptides were quantified by ELISA. ROC analysis was performed to evaluate possible diagnostic value of the peptides. While plasma levels of CGRP, VIP and PCT were significantly higher in patients with CAP than in the control group, respectively, NPY levels were significantly lower. Moreover, plasma levels of all neuropeptides and PCT were significantly higher in bacterial pneumonia patients compared to viral pneumonia patients. ROC analysis revealed that CGRP, SP and NPY had a diagnostic value in distinguishing viral and bacterial/mixed pneumonia.Conclusions: Our findings suggest that these neuropeptides may be implicated in pediatric CAP. CGRP, SP and NPY together may be a promising candidate in distinguishing viral and bacterial/mixed pneumonia, however, for this, further studies are needed.What is Known:center dot Neurogenic inflammation contributes to the development and progression of respiratory inflammatory diseases such as chronic obstructive pulmonary disease and bronchial asthma.What is New:center dot Plasma levels of neurogenic inflammation related neuropeptides calcitonin gene-related peptide, substance P, vasoactive intestinal peptide and neuropeptide Y are changed in pediatric community-acquired pneumonia. Calcitonin gene-related peptide, substance P and neuropeptide Y are promising candidates in distinguishing viral and bacterial/mixed pneumonia.
引用
收藏
页码:1619 / 1627
页数:9
相关论文
共 50 条
  • [1] Plasma levels of neurogenic inflammation related neuropeptides in pediatric patients with community-acquired pneumonia and their potential diagnostic value in distinguishing viral and bacterial pneumonia
    Mervan Bekdas
    Bilgi Saygi
    Yasemin Baranoglu Kilinc
    Erkan Kilinc
    European Journal of Pediatrics, 2024, 183 : 1619 - 1627
  • [2] Differentiation of bacterial and viral community-acquired pneumonia in children
    Don, Massimiliano
    Valent, Francesca
    Korppi, Matti
    Canciani, Mario
    PEDIATRICS INTERNATIONAL, 2009, 51 (01) : 91 - 96
  • [3] Diagnostic and Prognostic Value of Procalcitonin in Community-Acquired Pneumonia
    Horie, Masafumi
    Ugajin, Motoi
    Suzuki, Masaru
    Noguchi, Satoshi
    Tanaka, Wakae
    Yoshihara, Hisanao
    Kawakami, Masaki
    Kichikawa, Yoshiko
    Sakamoto, Yoshio
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2012, 343 (01) : 30 - 35
  • [4] Diagnostic value of blood parameters for community-acquired pneumonia
    Huang, Yukai
    Liu, Aihua
    Liang, Ling
    Jiang, Jiawei
    Luo, Haihua
    Deng, Weiming
    Lin, Guohui
    Wu, Maosheng
    Li, Tianwang
    Jiang, Yong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 64 : 10 - 15
  • [5] Viral and bacterial aetiology of community-acquired pneumonia in adults
    Huijskens, Elisabeth G. W.
    van Erkel, Adriana J. M.
    Palmen, Fernand M. H.
    Buiting, Anton G. M.
    Kluytmans, Jan A. J. W.
    Rossen, John W. A.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2013, 7 (04) : 567 - 573
  • [6] Plasma Kallistatin Levels in Children with Community-Acquired Pneumonia
    Hangul, Melih
    Ozturk, Didem
    Keti, Didem Barlak
    Demirkan, Fatma Guel
    Kose, Mehmet
    PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY, 2018, 31 (03) : 146 - 150
  • [7] Diagnostic and prognostic value of heparin-binding protein in pediatric community-acquired pneumonia
    Mohamed, Samah Abdelghany
    Elmeazawy, Rehab
    Sharaby, Radwa El
    Razik, Ahmed Abdel
    EGYPTIAN PEDIATRIC ASSOCIATION GAZETTE, 2024, 72 (01)
  • [8] Plasma kallistatin levels in patients with severe community-acquired pneumonia
    Lin, Wei-Chieh
    Lu, Shiou-Ling
    Lin, Chiou-Feng
    Chen, Chang-Wen
    Chao, Lee
    Chao, Julie
    Lin, Yee-Shin
    CRITICAL CARE, 2013, 17 (01):
  • [9] Inflammatory response in mixed viral-bacterial community-acquired pneumonia
    Bello, Salvador
    Minchole, Elisa
    Fandos, Sergio
    Lasierra, Ana B.
    Ruiz, Maria A.
    Simon, Ana L.
    Panadero, Carolina
    Lapresta, Carlos
    Menendez, Rosario
    Torres, Antoni
    BMC PULMONARY MEDICINE, 2014, 14
  • [10] Relationship between plasma copeptin levels and complications of community-acquired pneumonia in preschool children
    Du, Jian-Min
    Sang, Gao
    Jiang, Chun-Ming
    He, Xiao-Jun
    Han, Yong
    PEPTIDES, 2013, 45 : 61 - 65